Genoptix Files for IPO

Genoptix Inc., a Carlsbad, Calif.-based provider of personalized medicine services for management of hematolymphatic disorders, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol GXDX, with Lehman Brothers serving as lead underwriter. Genoptix has raised around $64 million in VC funding since 1999, from firms like Enterprise Partners, Chicago Growth Partners, William Blair Capital Partners, Alliance Technology Ventures, Tullis-Dickerson and Excelsior Venture Partners. www.genoptix.com